A vaccine that could ‘dramatically’
improve the treatment of multiple types of cancer is being given to patients
for the first time.
The potentially game-changing jab is
being trialled in Britons with prostate, lung and ovarian cancers.
Together these claim 51,000 lives a year
in the UK ? almost a third of all cancer deaths.
Although we usually think of vaccines as
preventing diseases, the term can also be applied to drugs that harness the
power of the immune system to treat them.
This new vaccine directs the immune
system to fight a protein that normally keeps cancer cells safe from harm.
